These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12015519)

  • 1. Endometrial thickness and uterine diameter not affected by ultralow doses of 17beta-estradiol in elderly women.
    Naessen T; Rodriguez-Macias K
    Am J Obstet Gynecol; 2002 May; 186(5):944-7. PubMed ID: 12015519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipid profile improved by ultra-low doses of 17 beta-estradiol in elderly women.
    Naessen T; Rodriguez-Macias K; Lithell H
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2757-62. PubMed ID: 11397883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine findings by transvaginal sonography during percutaneous estrogen treatment in postmenopausal women.
    Ylöstalo P; Granberg S; Bäckström AC; Hirsjärvi-Lahti T
    Maturitas; 1996 Apr; 23(3):313-7. PubMed ID: 8794426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
    Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.
    Johnson SR; Ettinger B; Macer JL; Ensrud KE; Quan J; Grady D
    Obstet Gynecol; 2005 Apr; 105(4):779-87. PubMed ID: 15802405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
    Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
    Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with endometrial thickness and uterine size in a random sample of postmenopausal women.
    Gull B; Karlsson B; Milsom I; Granberg S
    Am J Obstet Gynecol; 2001 Aug; 185(2):386-91. PubMed ID: 11518897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.
    Eriksen B
    Am J Obstet Gynecol; 1999 May; 180(5):1072-9. PubMed ID: 10329858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol/progesterone-releasing vaginal rings for hormone replacement therapy in postmenopausal women.
    Hamada AL; Maruo T; Samoto T; Yoshida S; Nash H; Spitz IM; Johansson E
    Gynecol Endocrinol; 2003 Jun; 17(3):247-54. PubMed ID: 12857433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonographic measurement of endometrial thickness during hormonal replacement therapy in postmenopausal women.
    Affinito P; Palomba S; Pellicano M; Sorrentino C; Di Carlo C; Morgera R; Arienzo MP; Nappi C
    Ultrasound Obstet Gynecol; 1998 May; 11(5):343-6. PubMed ID: 9644774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review.
    Sarkar NN
    Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):217-24. PubMed ID: 15006269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial safety of ultra-low-dose Vagifem 10 microg in postmenopausal women with vaginal atrophy.
    Ulrich LS; Naessen T; Elia D; Goldstein JA; Eugster-Hausmann M;
    Climacteric; 2010 Jun; 13(3):228-37. PubMed ID: 20423243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women.
    van Baal WM; Kenemans P; Stehouwer CD; Peters-Muller ER; van Vugt JM; van der Mooren MJ
    Am J Obstet Gynecol; 1999 Dec; 181(6):1365-73. PubMed ID: 10601914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of endometrial growth produced by unopposed conjugated estrogens or by micronized estradiol in postmenopausal women.
    Ettinger B; Bainton L; Upmalis DH; Citron JT; VanGessel A
    Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):112-7. PubMed ID: 9024100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone loss in elderly women prevented by ultralow doses of parenteral 17beta-estradiol.
    Naessen T; Berglund L; Ulmsten U
    Am J Obstet Gynecol; 1997 Jul; 177(1):115-9. PubMed ID: 9240593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal versus oral E(2) administration: effects on endometrial thickness, uterine perfusion, and contractility.
    Fanchin R; Righini C; Schönauer LM; Olivennes F; Cunha Filho JS; Frydman R
    Fertil Steril; 2001 Nov; 76(5):994-8. PubMed ID: 11704123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a unique constant-estrogen, pulsed-progestin hormone replacement therapy containing 17beta-estradiol and norgestimate on endometrial histology.
    Corson SL; Richart RM; Caubel P; Lim P
    Int J Fertil Womens Med; 1999; 44(6):279-85. PubMed ID: 10617249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.